Literature DB >> 20003637

Session 3 (Joint with the British Dietetic Association): Management of obesity: Weight-loss interventions in the treatment of obesity.

C R Hankey1.   

Abstract

Treatments to induce weight loss for the obese patient centre on the achievement of negative energy balance. This objective can theoretically be attained by interventions designed to achieve a reduction in energy intake and/or an increase in energy expenditure. Such 'lifestyle interventions' usually comprise one or more of the following strategies: dietary modification; behaviour change; increases in physical activity. These interventions are advocated as first treatment steps in algorithms recommended by current clinical obesity guidelines. Medication and surgical treatments are potentially available to those unable to implement 'lifestyle interventions' effectively by achieving losses of between 5 kg and 10 kg. It is accepted that the minimum of 5% weight loss is required to achieve clinically-meaningful benefits. Dietary treatments differ widely. Successful weight loss is most often associated with quantification of energy intake rather than macronutrient composition. Most dietary intervention studies secure a weight loss of between 5 kg and 10 kg after intervention for 6 months, with gradual weight regain at 1 year where weight changes are 3-4 kg below the starting weight. Some dietary interventions when evaluated at 2 and 4 years post intervention report the effects of weight maintenance rather than weight loss. Specific anti-obesity medications are effective adjuncts to weight loss, in most cases doubling the weight loss of those given dietary advice only. Greater physical activity alone increases energy expenditure by insufficient amounts to facilitate clinically-important weight losses, but is useful for weight maintenance. Weight losses of between half and three-quarters of excess body weight are seen at 10 years post intervention with bariatric surgery, making this arguably the most effective weight-loss treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20003637     DOI: 10.1017/S0029665109991844

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  5 in total

1.  Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women.

Authors:  Karen E Foster-Schubert; Catherine M Alfano; Catherine R Duggan; Liren Xiao; Kristin L Campbell; Angela Kong; Carolyn E Bain; Ching-Yun Wang; George L Blackburn; Anne McTiernan
Journal:  Obesity (Silver Spring)       Date:  2011-04-14       Impact factor: 5.002

2.  Interreality: the experiential use of technology in the treatment of obesity.

Authors:  Riva G; Wiederhold B K; Mantovani F; Gaggioli A
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-03-04

Review 3.  Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic Procedures.

Authors:  Hyunsoo Chung
Journal:  Clin Endosc       Date:  2017-05-31

Review 4.  Transdermal Drug Delivery Systems and Their Use in Obesity Treatment.

Authors:  Zhiguo Li; Xuexun Fang; Dahai Yu
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

5.  Changes in body weight, blood pressure and selected metabolic biomarkers with an energy-restricted diet including twice daily sweet snacks and once daily sugar-free beverage.

Authors:  Sharon M Nickols-Richardson; Kathryn E Piehowski; Catherine J Metzgar; Debra L Miller; Amy G Preston
Journal:  Nutr Res Pract       Date:  2014-11-05       Impact factor: 1.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.